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 A 3D model for bone sialoprotein has been constructed. 
 The model has an acidic surface patch that can interact with calcium ions. 
 The role of the protein in hydroxyapatite nucleation has been modelled. 
 Simulations indicate that the protein’s flexibility is important for nucleation. 
 Quantum calculations have been used to probe structure-function relationships. 
*Highlights (for review)
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ABSTRACT 
Human bone sialoprotein (BSP) is an essential component of the extracellular matrix of bone.  
It is thought to be the primary nucleator of hydroxyapatite crystallization, and is known to 
bind to hydroxyapatite, collagen, and cells.  Mature BSP shows extensive post-translational 
modifications, including attachment of glycans, sulfation, and phosphorylation, and is highly 
flexible with no specific 2D or 3D structure in solution or the solid state.  These features have 
severely limited the experimental characterization of the structure of this protein.  We have 
therefore developed a 3D structural model for BSP, based on the available literature data, 
using molecular modelling techniques.  The complete model consists of 301 amino acids, 
including six phosphorylated serines and two sulfated tyrosines, plus 92 N- and O-linked 
glycan residues.  A notable feature of the model is a large acidic patch that provides a surface 
for binding Ca
2+
 ions.  Density functional theory quantum calculations with an implicit 
solvent model indicate that Ca
2+
 ions are bound most strongly by the phosphorylated serines 
within BSP, along with reasonably strong binding to Asp and Glu, but weak binding to His 
and sulfated tyrosine.  The process of early hydroxyapatite nucleation has been studied by 
molecular dynamics on an acidic surface loop of the protein; the results suggest that the 
cationic nature of the loop promotes nucleation by attracting Ca
2+
 ions, while its flexibility 
allows for their rapid self-assembly with PO4
3-
 ions, rather than providing a regular template 
for crystallization.  The binding of a hydroxyapatite crystal at the protein’s acidic patch has 
also been modelled.  The relationships between hydroxyapatite, collagen and BSP are 
discussed. 
 
 
Keywords 
Hydroxyapatite; biomineralization; molecular modelling; osteogenesis; SIBLING proteins 
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1. Introduction 
Bone is a composite structure composed of mineral and organic components.  The mineral 
consists of small, tile-shaped crystals of carbonated hydroxyapatite (HA), where pure HA has 
the stoichiometric formula [Ca5(PO4)3(OH)].  The crystals are embedded in an organic matrix 
composed mainly of fibres of the structural protein type I collagen, as well as other proteins, 
of which the most abundant is bone sialoprotein (BSP) which accounts for up to ~15% of the 
non-collagenous protein [1].
 
 Mature human BSP has 301 amino acids and includes extensive 
and varied post-translational modifications that account for roughly one third of the 
molecular mass.  Zaia et al. analysed human BSP by MALDI-TOF and observed a peak for 
the as-extracted BSP centred at 52.5 kDa with a width of 11.9 kDa [2], reflecting the 
heterogeneous nature of the post-translational modifications.  Wuttke et al. similarly used 
MALDI-TOF to characterize recombinant and bone-derived BSP samples [3].  The 
recombinant BSP gave a broad peak between 40 – 75 kDa, average mass 57 kDa, whilst 
bone-derived BSP gave a peak between 40 – 60 kDa, average mass 49 kDa.  The mass of the 
core protein, calculated from its primary structure, is 33.5 kDa.  The modifications have been 
identified as N- and O-glycosylation, phosphorylation of serine and/or threonine, and 
sulfation of tyrosine residues.  Since the glycans include sialic acid residues, each of these 
modifications serves to increase the acidity of the mature protein, which already has a 
preponderance of acidic residues (60 Glu and 16 Asp, compared to 14 Lys and 9 Arg).  BSP 
sequences from various animal species are fairly similar and all contain regions of contiguous 
glutamic acid residues; human BSP has two (Glu)8 sequences. 
 In the absence of other proteins or ligands, BSP has little secondary structure and a 
highly variable tertiary structure.  Thus, one dimensional 
1
H NMR of recombinant BSP 
revealed that the protein is highly flexible along its entire length and exists as an ensemble of 
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completely unstructured conformations in solution [4].  Similarly, two dimensional HSQC 
NMR of an 
15
N labelled recombinant BSP fragment taken from the last 59 amino acids of the 
protein C-terminus indicated a rapidly flexing random coil structure [5].  Secondary structure 
prediction programs such as PsiPred [6] also suggest that the unmodified BSP would exist as 
an essentially unstructured random coil.  Circular dichroism (CD) spectroscopy of BSP 
indicated 5% α-helix, 32% β-sheet, 17% β-turn and 46% random coil [3], although it has 
been suggested that these values may over-estimate the helix and sheet content, due to a bias 
in the database of standard proteins used in the analysis [7].  Small angle X-ray scattering 
experiments on recombinant rat BSP gave results consistent with a random coil [7].  It seems 
likely that the structural elements suggested by CD are the averages for an ensemble of 
diverse and transient conformations.  Electron microscopy of recombinant BSP showed a 
monomeric structure, consisting of a globule of diameter 10 + 1 nm linked to a thread-like 
structure of 25 + 6 nm length [3].  In contrast, BSP isolated from bovine bone appeared as a 
simpler, threadlike structure with an average length of ~40 nm [8].  
 The biological function of BSP has yet to be fully defined.  Experiments using a 
steady state agarose gel system showed that BSP induces the crystallization of hydroxyapatite 
in vitro [9], supporting the commonly accepted view that BSP acts as a nucleator for growth 
of HA crystals within the extracellular bone matrix.  Further experiments showed that 
removal of the phosphate groups from mature BSP did not much diminish the protein’s 
ability to nucleate HA, whereas derivatisation of the glutamic acid residues abolished the 
ability.  Interestingly, this ability seems to be specific for glutamic acid; thus, poly(Glu) can 
nucleate HA, whereas poly(Asp) cannot [10].  BSP interacts strongly with HA crystals, with 
a dissociation constant of ~2.6  10-9 M for intact BSP from a rat osteosarcoma cell line [5].  
BSP also binds to type I collagen.  Tye et al. have probed the nature of this interaction in rat 
proteins, using bone-extracted BSP and recombinant peptides [11].  The interaction between 
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BSP and collagen was found to be partially electrostatic and partially due to more specific 
non-bonded interactions.  The poly(Glu) regions of BSP were found to be relatively 
unimportant in this context, whilst residues 19-46 provide specific short range interactions.  
These 28 residues are highly conserved across different species, and in humans include nine 
Tyr and Phe residues, plus five Arg and Lys residues.  The ability of recombinant BSP to 
nucleate HA is enhanced in the presence of collagen [11].  Since type I collagen itself binds 
to HA [1], it seems likely that BSP serves both to nucleate HA and also to enhance the 
interaction between the growing HA crystals and collagen.  Although it is also possible that 
BSP influences the shape of the HA crystals, which are remarkably thin in bone (ca. 3 nm), it 
has recently been shown that the surfaces of the crystals are decorated with strongly bound 
citrate, which accounts for 5.5% of the organic content of bone by weight; and this appears to 
be the main determinant of the crystal morphology [12]. 
 At the cellular level, BSP is expressed at high levels by osteoblasts under bone 
formation conditions, and at lower levels by odontoblasts, cementoblasts and hypertrophic 
cartilage cells.  Its patterns of expression and distribution are consistent with the hypothesis 
that BSP plays an essential role in HA nucleation, as well as formation and remodelling of 
bone [1,7].  Along with the related SIBLING (small integrin binding ligand, N-linked 
glycoprotein) protein osteopontin, BSP is expressed in malignant tissues, and indeed elevated 
serum levels of these proteins can be used to detect several types of cancer [13].  Expression 
of BSP is strongly associated with bone metastases in lung [14] and bone [15] tissues.  
 The primary amino acid sequences of BSP’s from a range of species include a well-
conserved RGD triplet near the C-terminus, which facilitates attachment of the protein to the 
integrins of several cell types [5].  Cell adhesion can also be accomplished independently of 
the RGD motif by two tyrosine-rich regions of BSP, one near the N-terminus and the other 
just before the RGD triplet.  The N-terminal region associated with cell adhesion overlaps to 
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a great extent with the collagen-binding region [11].  Since BSP binds strongly to HA, it is 
important that individual molecules of the protein are prevented from free diffusion into 
solution by anchoring on cells and/or collagen fibrils, since binding of multiple BSP 
molecules to a single crystal of HA could coat the surface and so poison further growth, as is 
observed for solutions of free BSP in vitro [5]. 
 Experimental determination of the structure of BSP is a highly desirable goal, but 
fraught with severe difficulties.  The lack of a fixed structure, together with the extensive but 
variable post-translational modifications, makes the crystallization of BSP for X-ray 
crystallography exceptionally difficult.  The NMR studies discussed above have shown only 
a lack of recognisable structural elements.  In these circumstances, the most useful structural 
information so far has come from mass spectrometric studies.   Two papers, both published in 
2001, have provided most of what is known about the post-translational modifications of 
human BSP [2,3].  Zaia et al. [2] characterized BSP extracted from human bone by MALDI-
TOF, as a broad peak centred at m/z 52,533, with a width of 11,850.  The broadness of the 
peak is consistent with a variable array of modifications.  Treatment with N-glycanase, O-
glycanase and neuraminidase allowed for partial characterization of the glycans and their 
points of attachment, whilst use of aminopeptidase M gave information about the most likely 
positions of sulfated tyrosine residues.  Based on their results, this group proposed two N-
linked oligosaccharides of composition (GlcNAc)5(Man)3(Gal)3(NeuAc)3 and 
(GlcNAc)6(Man)3(Gal)4(NeuAc)4, with Asn-161 and -166 as the most likely sites of 
N-glycosylation (note that throughout this paper, the residue numbering does not include the 
16-residue N-terminal signal peptide).  The O-linked oligosaccharides were proposed to have 
a total composition of (GalNAc)16(GlcNAc)4(Gal)15(Glc)6(NeuAc)16, divided among 16 
individual oligosaccharides.  Possible sites of O-glycosylation were deduced from the 
experimental data and bioinformatic analysis.  It was also possible to identify Ser-15 as being 
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phosphorylated, and a number of other phosphorylated serines were more tentatively 
proposed.  Two sulfated tyrosines were identified and traced to alternative pairs; either 
Tyr-259 or -262, and either Tyr-297 or -298.  These pairs flank the RGD domain and so 
could serve to modulate the interaction between BSP and integrin. 
 Wuttke and co-workers investigated human BSP, both as the bone-extracted protein 
and as a recombinant protein expressed in a human embryonic kidney cell line [3].  There 
were differences between the N-glycans of the extracted and recombinant proteins.  
Enzymatic cleavage of the glycans from the protein, followed by removal of the NeuAc 
residues with neuraminidase, HPLC, and MALDI-TOF analysis, allowed for the structural 
characterization of a variety of asialo-N-glycans, of which the most abundant type 
represented 57% of the total in bone-derived BSP.  Asparagines Asn-88, -161, 166 and -174 
were identified as the most likely sites of N-glycosylation.  Similarly, the O-glycans were 
cleaved from the protein and analysed by HPLC followed by MALDI-TOF.  Here again, 
there were differences in composition between the recombinant and extracted proteins; 
several glycans were structurally characterized and the most abundant glycan represented 
66% of the total in the bone-derived sample.  Seven threonines were suggested as O-
glycosylation sites. 
 Summing up, experimental studies have provided a body of data on the primary 
structure of BSP, which can be augmented by bioinformatic analysis.  Given the central role 
that BSP plays in bone growth, and that an experimental structure is unlikely to appear in the 
near future, we decided to construct a theoretical model for human BSP.  Since this protein 
clearly has little or no secondary structure and a highly variable tertiary structure, our main 
aim was to provide an initial 3D model for BSP that is consistent with all the available 
experimental data.  In order to provide further insights into the function of this protein, we 
have also probed the fundamental interactions between calcium cations and the available 
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anionic groups of BSP by quantum calculations, and investigated the nucleation of HA by a 
sub-section of our model, using molecular dynamics.  The results of our studies are presented 
in this paper. 
 
2. Computational methods 
2.1 Molecular mechanics modelling 
Initial phases of the molecular modelling were carried out using Hyperchem
TM
 release 8.0.8 
[16] to build small subsections of the molecule.  The complete model was assembled and 
refined using Accelrys Discovery Studio version 1.7 [17].  For the modified amino acids and 
glycan residues, formal fractional charges were set manually by dividing the total charge on 
the anionic group among its terminal oxygen atoms, and partial atomic charges were used as 
calculated by the software.  Interactive analysis of the effects of individual Ramachandran 
angles on the protein fold was carried out using the DeepView program [18].  Geometry 
optimizations were carried out with the CHARMm force field [19] and adopted basis 
Newton-Raphson algorithm to an RMS gradient of 0.1 kcal mol
-1
 Å
-1
.  In the Ramachandran 
plot of the final model, all non-glycine residues were within the ‘generously allowed’ 
regions, and all proline residues were within the ‘strictly allowed’ regions.  Geometry 
optimizations and molecular dynamics (MD) calculations used the generalized Born with 
simple switching (GBSW) implicit solvation model, with an implicit solvent dielectric 
constant of 80 and spherical cut-off electrostatics, non-bond list radius 14 Å, non-bond higher 
and lower cut-off distances of 12 and 10 Å respectively.  The SHAKE parameter was used 
for MD simulations but not for geometry optimizations.  The time step for all MD 
simulations was 0.002 ps.   
 
 
Page 11 of 38
Ac
ce
pte
d M
an
us
cri
pt
9 
 
2.2. Quantum calculations 
Density functional theory (DFT) calculations were run with Gaussian09W [20], using the 
B3LYP functional and water as implicit solvent for all calculations.  Geometry optimizations 
and frequency calculations were run using the 6-31G(d,p) basis set and Polarized Continuum 
Model implicit solvent corrections [21], whilst final energies were obtained for single point 
calculations at the optimized geometries, using the 6-311++G(3df,3pd) basis set and 
Solvation Model Based on Solute Electron Density implicit solvent corrections [22].  All 
reported structures were verified as minima by the absence of calculated imaginary 
frequencies.   
 
3. Results and discussion 
3.1 Primary and secondary structure of the model 
The primary amino acid sequence of human BSP was retrieved from the UniProt online 
database, accession code P21815.  The 16-residue N-terminal signal peptide was deleted to 
give the mature sequence.  This is shown in Figure 1, as a sequence alignment with BSP’s 
from seven other species.  All of the sequences have at least one region of eight or more 
contiguous glutamate residues, preceded by aspartates and/or potentially phosphorylated 
serines, extending these acidic regions.  In addition, there is a conserved DSSEE sequence 
just upstream of the first poly(Glu) region; if the serines in this sequence are phosphorylated, 
as suggested by the available experimental data (see below), this provides an additional patch 
of five contiguous acidic residues.  The chicken sequence is unique in having a third region 
of 12 contiguous glutamates.  Other important features of the sequence include a collagen 
binding region, a highly conserved RGD motif, and a cell binding region (see below).  During 
the construction of our model for BSP, four types of post-translational modifications were 
included; namely N-glycosylation, O-glycosylation, phosphorylation, and sulfation.  
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Although there is a shortage of definitive information on these modifications, the literature 
does provide sufficient data to allow reasonable assumptions concerning their positions and 
nature, as follows. 
 We start with the potential sites of N-glycosylation.  Wuttke et al. predicted four such 
sites, at asparagines Asn-88, -161, -166 and -174 [3].  Zaia et al. also noted four potential 
sites, but the mannose content of their protein suggested that only two of these are occupied 
[2].  Furthermore they were able to rule out Asn-88 from their mass spectrometric analysis, 
whilst Asn-174 is not universally conserved among mammalian BSP sequences, being His in 
the bovine sequence, for example (Figure 1).  Therefore, we have chosen Asn-161 and -166 
as the sites of N-glycosylation in our model.   To construct the N-glycan, we started with the 
most common species identified by Wuttke et al. which constituted 57% of the total asialo N-
glycan of extracted BSP.  Browsing the Functional Glycomics Gateway [23] suggested that 
the most plausible way to reconstruct the sialic acid residues would be via the commonly 
observed NeuAc(α-2-3)Gal linkage, which was also identified by Wuttke et al. in BSP O-
glycans.  Therefore, we added NeuAc residues to each of the three terminal Gal residues, 
giving the complete N-glycan shown in Figure 2.  This structure was subjected to preliminary 
MD in order to find a reasonable conformation, before splicing into the BSP model at the two 
sites noted above. 
 Progressing to the O-glycan, Zaia et al. deduced that the O-linked oligosaccharides 
have a total composition of (GalNAc)16(GlcNAc)4(Gal)15(Glc)6(NeuAc)16, divided among 16 
individual oligosaccharides.  Meanwhile, Wuttke et al. were able to characterize a number of 
different O-linked glycans in their sample of bone-extracted BSP, finding that the most 
abundant of these accounted for 66% of the total.  We chose this species for all the O-linked 
glycans in our model (Figure 2).  At present, there is no firm evidence or consensus as to 
exactly which sites are O-glycosylated in human BSP.  Experimental studies using a Galnt1-
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null mouse model have revealed the sites of O-glycosylation in mouse BSP, but not all of 
these are conserved between the human and mouse sequences [24].  We decided to score each 
of the possible O-glycosylation sites based on the overall consensus between the mouse 
studies, the proposed sites of Zaia et al. and Wuttke et al., the conservation of each residue 
across the sequence alignment shown in Figure 1, and the predictions of the NetOGlyc server 
[25].  We then selected the eight most likely sites on this basis.  The highest scoring site was 
Thr-223, which received the highest score from NetOGlyc (0.70), is conserved in six out of 
eight of the amino acid sequences, and was identified in all three experimental studies.  The 
lowest scoring site selected was Thr-211, which scored 0.68 from NetOGlyc, is also 
conserved in six out of eight sequences, and was identified by Wuttke but not by Zaia or the 
mouse studies.  Eight O-glycosylation sites may be slightly lower than the number found in a 
typical molecule of BSP, but this would probably not have a major effect on the overall 
structure of the protein.   
 As for the sulfation sites, Zaia et al. identified Tyr-259 or -262 and Tyr-297 or -298 as 
being sulfated from their experiments.  These four residues are generally well conserved, 
with the exception of Tyr-259 which is Glu in the chicken sequence (Figure 1).  Therefore, in 
order to choose between the alternatives, we searched the Protein Data Bank [26] for proteins 
containing sulfated tyrosines with local sequences comparable to those found in BSP 
(considering four residues on each side of the tyrosine and scoring alignments with the 250 
PAM mutation data matrix).  In this way, we identified BSP Tyr-262 as the more likely of the 
first pair, by local alignment with one of the three sulfated tyrosines in PDB structure 2K05 
[27] [Figure 3(a)].  This also fits with the sequence conservation considerations noted above.  
We were unable to find a comparable sulfated sequence for either of the second pair of 
tyrosines in the PDB.  However, internal comparison of the local sequences for the four BSP 
tyrosines gave a clearly better PAM score for Tyr-262 plus Tyr-298 compared to the other 
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three permutations [Figure3(b) and (c)].  Therefore, Tyr-298 was taken as the second of the 
two sulfated tyrosines. 
 Finally, we considered the most likely sites of phosphorylation. On average, BSP has 
six phosphorylated serine or threonine residues [1,28], and Ser-15 has been positively 
identified as one of these [2].  Once again, however, there is no hard evidence as to the other 
sites of phosphorylation in human BSP.  Studies on rat BSP identified Ser-15, Ser-50, Ser-51 
and Ser-136 as phosphorylated, all of which are conserved in the human protein; moreover 
Ser-136 was identified as critical for HA nucleation [28].  Detailed experimental studies of 
the bovine protein have identified a total of eleven phosphorylated serines [29,30], of which 
nine are conserved in human BSP.  Using this information, together with predictions from the 
NetPhos server [31] and our sequence alignment, we chose the six phosphorylation sites 
included in our model (Figure 1).  These all scored 0.988 or better in NetPhos and were 
conserved in at least seven of the eight sequences in our alignment; in addition, the 
corresponding bovine residues were identified as phosphorylated [29,30].  Having chosen all 
these post-translational modifications, the primary structure of our model is as shown in 
Figure 1.  It is worth pointing out that although there is a degree of uncertainty over several 
of these assignments, small changes in the primary structure of our model would not 
materially affect its overall 3D structure or our functional modelling studies.  Moreover, since 
natural BSP is itself inhomogeneous, with different molecules supporting a variety of post-
translational modifications, our model should be considered as a representative example of 
the structure, rather than an attempt to provide a single definitive model. 
 As discussed in the Introduction, the general consensus from experimental studies is 
that free BSP is highly dynamic, with no regions of fixed secondary structure.  Therefore, to 
construct our 3D model, we initially chose random backbone φ and ψ angles for each residue, 
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within the constraints of the Ramachandran plot.  This gave an initial extended conformation 
which was subsequently modified, as discussed below. 
 
3.2 Tertiary structure of the model 
Wuttke et al. used electron microscopy to visualize recombinant BSP as a globule attached to 
a threadlike structure [3].  We decided to use this as a basis for building the 3D conformation 
of our model.  In the absence of any means of identifying which part of the protein formed 
the globule, it was suggested on the basis of the distribution of glycans that the globule would 
correspond to the C-terminal part of the protein.  However, our analysis of the available data, 
discussed above, indicates that the glycans are clustered around the central part of the amino 
acid sequence.  We have therefore reconsidered this question from the point of view of the 
distribution of hydrophobic, basic and acidic residues.  Since the protein is dominated by 
acidic residues, the hydrophobic and basic residues would seem to be the most likely 
candidates to aggregate into a globule; the former due to the normal hydrophobic effects, and 
the latter due to electrostatic attraction to the neighbouring acidic residues.  Considering the 
primary sequence, the region of the protein most likely to form the interior of a molten 
globule is then the N-terminus, specifically residues 1 – 12 and 18 – 47.  We therefore 
adjusted the φ and ψ angles of individual residues to form a molten globule structure, starting 
from the N-terminus.  This still allows all the modified amino acid residues and glycans to 
occupy surface positions, as would be expected for these hydrophilic groups.  According to 
Wuttke et al. [3], the diameter of the globule is 100 Å and the length of the thread is 250 Å, 
meaning that the globule constitutes ~30% of the total length of the molecule.  We 
constructed our model on this basis, meaning that the residues from the N-terminus up to 
Glu-244 were built into the globule.  Residue Glu-244 comes at the start of the C-terminal 
cell binding region (Figure 1).  We included 30 Ca
2+
 ions, distributed among the most acidic 
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portions of the amino acid sequence.  Our initial model was refined by local annealing to 
remove close contacts and/or strained local geometry, followed by a final global energy 
minimisation, using the GBSW implicit solvation model throughout.  This gave an irregular 
globule of ~55 Å diameter, plus a thread of ~145 Å.  Although these dimensions are both 
smaller than those given by Wuttke, the ratio is similar.  To put these values into context, a 
compactly folded spherical protein of equivalent molecular weight to our entire model would 
have a diameter of ~52 Å (based on the mean diameter of the near-spherical protein 1UG6 
[32], which has a molecular weight of 48.4 kDa).  Hence, unless BSP has a very open 
structure, it seems possible that the experimental dimensions may be somewhat over-
estimated.   
 Figure 4 shows the overall structure of our model.  It includes 30 calcium ions and has 
a molecular weight of 48,870, which fits within the range observed by MALDI-TOF [2,3], 
bearing in mind that our model contains no water molecules.  The overall charge is -30.  All 
of the glycan residues lie in a ring on the surface of the globule, covering ~34% of its surface 
area.  A key feature of this model is that the most acidic stretches of the amino acid sequence 
are contiguous such that there is a large patch of acidic residues on one face of the globule.  
This includes 22 Glu, 5 Asp and all 6 phosphoserines in our model, giving an overall charge 
for the patch of 39-.  This arrangement is stabilised by the calcium ions, such that the region 
carries a net positive charge. When the calcium ions are deleted, the surface of the model 
clearly shows the acidic patch (Figure 5).  A few of the calcium ions lie within the globule, 
but most are on the surface in a way that suggests they could be transformed fairly easily into 
a more crystalline arrangement.  In order to test this idea, we used the published crystal 
structure of human dental HA [33] to construct a nanocrystal of approximate dimensions 48  
41  13 Å for docking to our model.  We replaced 20 of the individual calcium ions in our 
model with the nanocrystal; in order to achieve satisfactory results from subsequent geometry 
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optimization, we also deleted four of the calcium ions from the surface layer of the 
nanocrystal, allowing the phosphoserines to occupy the resulting voids.  Overall, this allows 
for an intimate association between the protein and the nanocrystal, as shown in Figure 6.  
The contact area between the crystal and the protein is ~ 640 Å
2
.  Although this is rather less 
than half the size of a typical protein-protein interface [34], the nature of the BSP-nanocrystal 
interface is very different, being dominated by ionic rather than non-polar interactions.  
Taken with the results of our quantum calculations (see below), our model is entirely 
consistent with the idea that BSP forms a strong association with the HA crystals in bone.   
 Studies on rat BSP2 showed that residues 18 - 45 provide the collagen binding site 
[11].  This part of the sequence is well conserved and dominated by hydrophobic and basic 
residues (Figure 1).  Since we assumed that these types of residue would help form the 
molten globule, in our model, this part of the sequence is located at its centre, near to but 
distinct from the HA binding site.  It seems likely that facile rearrangement of the globule 
would allow BSP to effectively become threaded onto the collagen triple helix, whilst 
preserving the HA binding surface.  Interestingly, the collagen binding region has also been 
shown to support attachment of BSP to cells, in addition to the cell binding region just in 
front of the RGD motif [5].  Hence, the N-terminal region can apparently bind either to the 
cell or to collagen, but not to both at the same time.  This may provide a basis for BSP 
molecules to be transferred from the cell surface to collagen, in which case sulfation of the 
C-terminal tyrosines could help to complete the transfer. 
 
3.3 Dynamic modelling of hydroxyapatite nucleation 
We next considered how BSP might serve as a nucleator for HA.  This question has recently 
been addressed by two different groups, using MD simulations.  In their MD calculations, 
Sahai and co-workers [35,36] used a model peptide of sequence S
P
S
P
EEEEEEEE (S
P
 = 
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phosphoserine) in a periodic box with explicit solvent plus Ca
2+
 and Pi
 
ions (Pi = HPO4
2-
 or 
H2PO4
-
).  The peptide was in either α-helical or random coil conformations.  The first 1 ns of 
the simulation was used for equilibration, and the data collections lasted for up to 35 ns.  On 
this timescale, Ca
2+
 ions remained localized on the peptide sidechains, with no exchange 
during the simulations.  A notable feature for the α-helical peptide model was the transient 
formation of equilateral triangles of Ca
2+
 ions and it was suggested that the protein could 
serve as a template for the formation of such triangles, which are related to the geometry of 
Ca
2+
 ions on the (001) face of HA.  Nevertheless, based on the relative scarcity of these 
structures in their simulations, the authors concluded that BSP is more likely to nucleate 
amorphous calcium phosphate rather than crystalline HA.  Upon extending their studies to 
consider binding of the S
P
S
P
EEEEEEEE peptide to different faces of the HA crystal, there 
was no obvious structural templating effect from the peptide, which could be accommodated 
on the (001), (100) and (110) crystal faces.  Baht et al. used MD to simulate the association 
of two different glutamate-rich 16-mers from the rat protein, both with and without 
phosphorylated serines, with the (100) face of HA [28].  They used a simple point charge 
solvent model and a periodic box for these simulations.  They found that the peptides tend to 
show an alternating pattern of residues pointing towards and away from the crystal face. 
 For our MD studies, we extracted a 24 residue segment from our model for BSP, 
consisting of the sequence SSDS
P
S
P
EENGDDS
P
S
P
EEEEEEEETSN.  The terminal residues 
were fixed according to their spatial arrangement in the complete model, and simulations 
were run using the GBSW implicit solvent model.  We also used fully deprotonated PO4
3-
 
ions, with no periodic boundary conditions; although a small number of the simulations failed 
due to random diffusion of an ion away from the peptide, both the Ca
2+
 and PO4
3-
 ions tended 
to remain associated with the protein provided that the overall charge on the system was kept 
close to zero.  In order to validate this approach, we first modelled the calcium binding sites 
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of the sodium/calcium exchange protein 2QVM [37].   This protein structure has two surface-
accessible Ca
2+
 ions, coordinated by Asp and Glu residues.  A 20 ns simulation of the 
calcium binding region using our standard conditions showed that both Ca
2+
 ions remained 
within their experimentally determined binding sites, with only minor fluctuations in their 
coordination environments and the overall energy and fold of the model throughout the 
simulation. 
 Returning to BSP, since we were particularly interested in the behaviour of this 
system before an equilibrium state is reached, we used two different methods to probe the 
dynamic behaviour, which gave very similar results.  First, we used a very short heating 
phase of 14 ps, followed directly by a production phase of 20 ns.  Alternatively, we 
introduced a set of seven distance constraints to keep the five PO4
3-
 ions separated by their 
initial distances (these ranged from 7.2 - 16.2 Å) during a heating phase of 0.2 ns, followed 
by an equilibration phase of 1.0 ns; the constraints were then removed for a simulation of 20 
ns.  Figure 7 shows a typical energy-time plot from these calculations.  After an initial rapid 
stabilization phase, the plot shows characteristic stepwise decreases in the total energy of the 
system that take place over ~0.1 ns, separated by constant energy states that persist for ~1 - 
10 ns.  Most of the energy decreases are associated with the spontaneous self-assembly of 
PO4
3-
 and/or phosphoserine phosphate groups with Ca
2+
 ions, whilst the others can be related 
to changes in the peptide backbone conformation.  A typical Ca
2+
 - PO4
3-
 assembly event is 
shown in detail in Figure 8; the clustering of the four Ca
2+
 ions with three PO4
3-
 ions in this 
example is associated with a permanent decrease in the energy of the system.  Throughout all 
our simulations, once phosphate groups became associated via bridging calcium ions, they 
remained together for the rest of the calculation.  As expected, the overall conformation of 
the loop varied quite markedly throughout the simulations and also from run to run.  These 
observations suggest that although the peptide clearly facilitates HA nucleation, it should not 
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be described as a template; rather, its highly flexible structure allows it to respond to the 
movements of the anions and cations as they undergo spontaneous self-assembly.  The 
primary role of the acidic loops is then to attract calcium ions, which in turn attract 
phosphates.  This is consistent with experiments that show the poly(Glu) regions are essential 
for HA nucleation [10], and is also supported by the results of our quantum calculations (see 
below).  The aggregated ions then begin to pack around the peptide strand, and in particular 
the phosphoserines, which become tightly integrated into the growing mass of amorphous 
calcium phosphate.  We suspect that the mature HA-BSP interface may be characterized by a 
transition from an intimate and amorphous protein-calcium phosphate mixture to the regular 
structure of the bulk nanocrystal, rather than a simple association of the protein with a crystal 
surface. 
 
3.4 Ion binding energies from quantum calculations 
An important consideration is the strength of interactions of calcium ions with both free 
phosphate, and the available acidic groups on the protein.  We have investigated these 
interactions by DFT quantum calculations.  We begin by noting that we are interested in the 
interactions between various ionic species at the protein-water interface.  Therefore, it is 
essential to take solvent effects into account during geometry optimizations, since the gas 
phase structures of the ion pairs will be markedly different.  We therefore used implicit 
solvent models for both geometry optimizations and final energy calculations with a large 
basis set (see Computational Details).  The results are shown in Table 1.  We have included 
zero point energy (ZPE) corrections but not basis set superposition corrections, which cannot 
easily be calculated for highly polarised systems such as [Ca(PO4)]
-
.  Trial gas phase 
calculations on [Ca(OH2)]
2+
 and [Ca(MeCO2)]
+
 gave basis set superposition errors of  0.6 and 
1.1 kJ/mole respectively, which can be considered as negligible.   
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 We start by considering the solvation condition of the Ca
2+
 ion.  This has been the 
subject of numerous experimental and theoretical studies; the consensus is that the 
coordination number of Ca
2+
 in water is 6 - 8, with Ca-O distances typically 2.4 - 2.5 Å and 
an exchange rate of ca. 10
9
 - 10
11
 s
-1
 [38-40].  Our DFT calculations on the aqua ions 
[Ca(H2O)n]
2+
 (n = 5 - 9) indicate that individual water ligands bind very weakly to Ca
2+
, with 
binding energies less than typical hydrogen bond energies (Table 1).  This is consistent with 
the rapid exchange rates noted above.  It is worth remembering that the Ca
2+
 ion is 
nevertheless strongly solvated in water; our method gave calculated solvation energies ∆Esolv 
of -1606 to -1647 kJ/mole for the processes Ca
2+
(gas) → [Ca(OH2)n]
2+
(aq) (n = 5 - 9).  
Experimental estimates of the free energy of solvation ∆Gsolv for Ca
2+
 are in the range of 
-1505 to -1657 kJ/mole [40,41].  
 We next considered the binding energies of calcium with free phosphate and the 
various ligands available to BSP.  We modelled the individual amino acids as the fragments 
CH(O)NHCH(R)C(O)NH2, where R is the required sidechain, and the backbone atoms were 
in the β-sheet conformation.  All of the anionic ligands in Table 1 were bidentate in the 
optimized structures.  We also considered a larger model, consisting of a 
CH(O)[NHCH(CH2CH2CO2)C(O)]2NH2 fragment, designated as GluGlu in Table 1, as a 
model for successive Glu residues.  For these larger models, several different initial backbone 
geometries were considered; the lowest energy conformation in each case proved to be the β-
turn geometry, incorporating an internal hydrogen bond between the terminal CH(O) and 
NH2 groups, although the energies of some of the alternative conformations lacking this 
hydrogen bond were not much higher (< 10 kJ/mole).  The first point of note is that as might 
be expected for ionic bonding, the strength of Ca
2+
 binding by the various oxyanions 
correlates with the formal fractional charge on the O-donor atoms.  This varies from -3/4 for 
PO4
3-
 to -1/3 for sulfotyrosine; a plot of (∆E + ZPE) versus fractional charge for the seven 
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oxyanions in Table 1 gave a straight line with R
2
 = 0.96.  The strongest interaction is thus 
between Ca
2+
 and PO4
3-
, followed by HPO4
2-
.  The calculations on the phosphoserine model 
indicate that binding of Ca
2+
 to this residue is also strong, and in particular clearly stronger 
than the single carboxylic acids.  Therefore, the phosphoserines provide the strongest 
association between the protein and HA.  Individual carboxylate donors show reasonably 
favourable binding to Ca
2+
; Asp is slightly inferior to Glu, which can be explained by a weak 
internal hydrogen bond between the carboxylate and the NH group of the Asp residue in the 
free ligand, which is lost upon Ca
2+
 binding.  The extended GluGlu model shows that a single 
Ca
2+
 can be favourably coordinated by two adjacent carboxylate groups, however the energy 
gain from coordination of the second carboxylate to the single Glu-Ca
2+
 moiety (-18.7 
kJ/mole including the ZPE) is less than that for capture of a second Ca
2+
 ion (-30.1 kJ/mole 
including the ZPE).  This suggests that provided the local Ca
2+
 ion concentration is 
sufficiently high, the poly(Glu) regions of BSP preferentially interact with one Ca
2+
 ion per 
glutamate.  This seems to us to be an important point, since it suggests that whereas the 
phosphoserines will form neutral ion pairs with single Ca
2+
 ions, the glutamates in the 
poly(Glu) regions of the protein are able to interact with sufficient numbers of Ca
2+
 ions to 
require free phosphate anions for charge neutralization, so promoting HA nucleation.  This is 
also consistent with experiments that show that the poly(Glu) regions but not the 
phosphoserines are critical for HA nucleation [10].  Finally, both histidine and sulfotyrosine 
gave weak binding energies, not much better than the values for water ligands, therefore the 
interactions of these residues with Ca
2+
 are unlikely to be important for HA nucleation or 
binding. 
 Summing up, the DFT and MD calculations suggest that the surface patch of 
glutamate residues serves to increase the local concentration of Ca
2+
 and phosphate ions by 
electrostatic attraction.  These loose assemblies of ions rapidly become compacted as the free 
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ions self-assemble into a more regular arrangement that optimizes the strong electrostatic 
attractions between Ca
2+
 and phosphate.  The highly flexible protein chain facilitates rapid 
assembly of the inorganic ions, and also becomes intimately associated with the growing 
mineral, especially by means of the strong interactions between Ca
2+
 and phosphoserine, such 
that there is a strong association between BSP and the mature HA crystal. 
 
3.5 Analysis of the composition of bone 
Some interesting further insights into the biological function of BSP can be gleaned from 
analysis of the composition of the main components of bone.  The overall composition is 65 
wt. % mineral, 25 wt. % organic, and 10 wt. % water [42].  Collagen accounts for 90% of the 
organic component [8], while BSP comprises 8 – 15% [1,43] of the non-collagenous protein.  
The HA crystals are quite variable in size, but their typical dimensions from TEM have been 
given as (30-50)  (15-30)  (2-10) nm [42].  Taking the averages of these values, together 
with the density of 3.021 g/cm
3
 for human dental HA [33], we can calculate that 1 g of bone 
contains 4.0  1016 individual crystals.  Taking molecular weights for the collagen triple helix 
and BSP of 288 and 50 kDa respectively, 1 g of bone will also contain 4.7  1017 collagen 
trimers and (2.4 - 4.5)  1016 molecules of BSP.  In other words, the ratio of individual HA 
crystals to BSP molecules to collagen trimers is in the region of 1:1:12.  Allowing due 
caution for the approximate nature of these calculations, we suggest that a ratio of one HA 
crystal per BSP molecule is entirely consistent with BSP being the key nucleator of HA 
crystal growth. 
 Comparison of the relative sizes of these three components is also instructive.  Figure 
9 shows our BSP model, together with a crystal of dimensions 40  22.5  6 nm and the 
experimentally determined structure of a collagen trimer [44].  Note that the latter consists 
only of the α-carbon trace, so is a little thinner than the complete molecule.  A single BSP 
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molecule is clearly too small to be able to control the morphology of the crystals; a role that 
has in any case recently been assigned to citrate [12].  On the other hand, BSP could well 
anchor each crystal to a single collagen trimer within a fibril. 
 
4. Conclusion 
The model of BSP described here is consistent with a scenario in which the protein acts both 
to nucleate hydroxyapatite crystallization and to anchor the growing crystals to the 
surrounding collagen fibrils.  It has been pointed out that the physical condition of mineral-
nucleating proteins is important for their correct function [9,10]; proteins that can initiate 
crystal nucleation when isolated by immobilisation may poison crystal growth when free in 
solution.  Therefore, we suggest that individual BSP molecules are kept separate by initial 
deployment to the cell surface, being attached at both the N- and C-termini.  Transfer to 
collagen by means of the N-terminal collagen binding region would be followed by 
dissociation of the C-terminal from the cell (perhaps involving tyrosine sulfation).  Once 
threaded onto the collagen fibril, BSP would then serve to nucleate HA crystallization by 
electrostatic attractions between the surface acidic patch and calcium ions.  Finally, BSP can 
promote attachment of the mature HA crystal to the fibril, especially by means the strong 
attraction between its phosphorylated groups and calcium ions within the mineral matrix.  We 
now plan to use our 3D model for BSP as a starting point for more extensive dynamics 
studies.  
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Table 1   
Calculated bond lengths and binding energies for Ca
2+
 complexes of ligands available in the 
BSP environment. 
complex Ca-O/N bond lengths, 
Å 
∆E, kJ/molea ∆E + ZPE, kJ/molea 
[Ca(PO4)]
- 
2.279, 2.280 -103.9 -99.6 
[Ca(HPO4)] 2.352, 2.352 -77.0 -73.6 
[Ca(phosphoserine)] 2.358, 2.366 -72.6 -68.9 
[Ca(MeCO2)]
+ 
2.432, 2.433 -54.9 -50.5 
[Ca(glutamate)]
+ 
2.425, 2.430 -53.3 -47.3 
[Ca(aspartate)]
+ 
2.435, 2.453 -47.0 -42.0 
[Ca(GluGlu)]
b 
2.426, 2.435 -54.2 -48.8 
[Ca(GluGlu)]
c 
2.305, 2.458, 2.463 -76.6
 
-67.5 
[Ca2(GluGlu)]
2+ 
2.385 - 2.489 -56.2
d
 (-35.8)
 
-48.8
d
 (-30.1)
 
[Ca(histidine)]
2+ 
2.532 -19.3 -15.9 
[Ca(sulfotyrosine)]
+
 2.519, 2.549 -13.1 -9.9 
[Ca(H2O)5]
2+ 
2.435 - 2.519 -13.7
e 
-6.0
e 
[Ca(H2O)6]
2+ 
2.461 - 2.538 -11.7
e
  (-1.9)
 
-3.0
e
 (+11.6)
 
[Ca(H2O)7]
2+ 
2.456 - 2.574 -10.3
e
  (-1.9)
 
-1.2
e
 (+9.9)
 
[Ca(H2O)8]
2+
 2.552 - 2.566 -9.1
e
  (-0.9)
 
+0.4
e
 (+11.8)
 
[Ca(H2O)9]
2+
 2.533 - 2.645 -7.9
e
  (+1.8)
 
+1.3
e
 (+8.5)
 
 
a 
Values in parentheses are for addition of a successive Ca
2+
 or water to the species in the row 
immediately above. 
b
 Model with Ca
2+
 bound to a single η2 carboxylate. c Model with Ca2+ 
bound to both carboxylates (η1,η2 coordination). d average value for a single Ca2+. e Average 
value for a single water ligand. 
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Figure legends 
 
Fig. 1.  Sequence alignment for BSP’s from man (P21815), mouse (mse, Q61711), rat 
(Q3HLN4), golden hamster (ham, P70113), cow (Q28862), pig (P31936), dog (XP_851449) 
and chicken (hen, P79780).  The labels on the top line indicate the post-translational 
modifications in our model; P  = phosphorylated serine, G = glycosylated asparagine or 
threonine, S = sulfated tyrosine.  In addition, the two patches of contiguous glutamate 
residues in the human sequence are indicated by numbers in square brackets, and the RGD 
sequence common to all the proteins is indicated.  Sequences were retrieved from the UniProt 
database, except for the dog sequence which was retrieved from the NCBI database. 
 
Fig. 2.  (a) N-glycan and (b) O-glycan used in the model.  NeuAc = N-acetyl neuraminic 
acid; Gal = galactose; GlcNAc = N-acetyl-D-glucosamine; Man = mannose; Fuc = fucose; 
GalNAc = N-acetyl-D-galactosamine. 
 
Fig. 3.  Local sequence comparisons to identify the most likely sites of tyrosine sulfation.  
The numbers in parentheses are the PAM 250 scores (neglecting the highlighted central 
tyrosine).  (a) Comparisons of tyrosines 259 and 262 with a known sulfated tyrosine from 
protein 2K05;  (b) internal comparisons of tyrosine 297 with 259 and 262; (c) internal 
comparisons of tyrosine 298 with 259 and 262.  Comparison of the 2K05 sequence with 
tyrosines 297 and 298 scored -7 and +3 respectively. 
 
Fig. 4.  Picture of the BSP model.  The protein chain is rendered as a yellow ribbon; regions 
of five or more contiguous acidic residues (including phosphoserines) are coloured red.  
Glycans are rendered in stick mode; N-glycans and O-glycans are coloured dark blue and 
light blue respectively.  In this projection, the N-glycans lie behind the protein globule and 
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most of the O-glycans are in front. Ca
2+
 ions are rendered as green spheres. The sidechains of 
the RGD motif are shown in magenta, and the sidechains of the two sulfated tyrosines are 
shown in orange.  H atoms are omitted for clarity. 
 
Fig. 5.  Solvent surface (2.5 Å probe) of the BSP model after deletion of all the Ca
2+
 ions, 
coloured according to electrostatic potential (red = negative, blue = positive).  (a) View of the 
complete molecule, showing the negatively charged surface patch; (b) view of the opposite 
side of the globule. 
 
Fig. 6.  Complex between the BSP model and a crystal of calcium hydroxyapatite of 
approximate dimensions 48  41  13 Å.  Calcium atoms are coloured green; sugars are 
coloured blue, and the protein is coloured yellow.  H atoms and the C-terminal region of the 
protein (residues 263-301) are omitted for clarity.  (a) Overall view; the collagen binding 
region is highlighted in magenta.  (b) Slab view, showing a section through the protein-
crystal interface; Asp and Glu residues are coloured red, and phosphoserine residues are 
coloured cyan.   
 
Fig. 7.  Typical plot of total energy versus time for MD simulation of the interactions of the 
acidic loop with Ca
2+
 and PO4
3-
 ions.  The numbered regions are associated with self-
assembly of Ca
2+
, PO4
3-
 and phosphoserine groups; event 1 involves phosphoserines 50 and 
59 plus two PO4
3-
 ions; event 2 involves phosphoserines 51 and 58; event 3 involves 
phosphoserine 59 plus one PO4
3-
; and event 4 involves three PO4
3-
 ions.  The average P···P 
distance for the associating groups is 8.8 + 0.6 Å immediately before and 5.3 + 0.8 Å 
immediately after these events.   
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Fig. 8.  A typical phosphate association event from the molecular dynamics calculations.  (a) 
structure immediately before the association; (b) structure immediately after the association; 
(c) plots of P···P distances and total energy versus time during the association event.  The 
associating Ca
2+
 and PO4
3-
 ions are highlighted; other Ca
2+
 ions are rendered as small green 
spheres.  The P···P distances between the three PO4
3-
 groups are 4.1, 10.4 and 13.0 Å before 
association, reducing to 4.1, 4.8 and 6.5 Å after association. The four highlighted Ca
2+
 ions 
are located between the PO4
3-
 ions (the Ca···P distances are 2.8 - 3.7 Å).  Note also 
phosphoserine-58, whose P atom is coloured magenta; the phosphate of this group is also part 
of the self-assembled calcium phosphate cluster.  
 
Fig. 9.  Relative sizes of BSP, a typical hydroxyapatite crystal, and a collagen trimer.  The 
collagen is rendered as CPK atoms scaled  2, since only the α-carbons are included. 
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Figure 1 
 
 
 
 
 
 
Figure 2 
 
 
 
 
 
 
P ······collagen binding······ PP PP··[1]···
man FSMKNLHRRVKIEDSEENGVFKYRPRYYLYKHAYFYPHLKRFPVQGSSDSSEENGD-DSSEEEEEEEETSNEGENN---EESNEDEDSE--AENTTLS---ATTLGYG 99
mse FSMKNFHRRIKAEDSEENGVFKYRPRYFLYKHAYFYPPLKRFPVQGGSDSSEENGDGDSSEEEGEEEETSNEEENN---EDSEGNEDQEAEAENATLSTLSGVTASYG 105
rat FSMKNFHRRIKAEDSEENGVFKYRPRYFLYKHAYFYPPLKRFPVQGGSDSSEENGDGDSSEEEGEEEETSNEEENN---EDSEGNEDQEAEAENATLS---GVTASYG 102
ham FSMKNFHRRVKAEDSEDNGVFKYRPRYFLYKHAYFYPSLKRFSVQGGSDSSEENGDGDSSEEEGEEE-TSNEEENN---EESEGNEDEEAEAENTTLS---SVTTSYG 101
cow LSMKNLNRRAKLEDSEENGVFKYRPQYYVYKHGYFYPALKRFAVQSSSDSSEENGNGDSSEEEEEEEETSNEEGNNGGNEDSDENEDEESEAENTTLS---TTTLGYG 105
pig FSMKNFHRRAKLEDPEENGVFKYRPRYYLYKHAYFYPPLKRFPVQSSSDSSEENGNGDSSEEEEEEEENSNEEENNEENEDSDGNEDEDSEAENITLS---TTTLGYG 105
dog FSMKNLHRRAKLEDSEENGVFKYRPRYYLYKHSYFYPPLKRFPVQSSSDSSEEDGDGDSSEEEEEEEETSNEEENNEENANSDENEDE-SDAENSTLS----ATPGYG 103
hen FSVRSWLRRARAGDSEENAVLKSRHRYYLYRYA--YPPLHRY---KGSDSSEEEGDG--SEEEEEGGAPSHAGT--------------QAAGEGLTLG---------- 77
G                               P ··[2]··· G    G
man EDATPGTGYTGLAAIQLPKK--AGDITNKATKEKESDEEEEEEEEGNENEESEAEVDENEQGINGTSTNST-EAENGNGSSGGDNGEE--GEEESVTGANAEDTTETG 202
mse AETTPQAQTFELAALQLPKK--AGDAESRAPKVKESDEEEEEEEEEEENENEEAEVDENELAVNGTSTNST-EVDGGNGSSGGDNGEEAEAEEASVTEAGAEGTTG-G 209
rat VETTADAGKLELAALQLPKK--AGDAEGKAPKMKESDEEEEEEEEEE-NENEEAEVDENEQVVNGTSTNST-EVDGGNGPSGGDNGEE--AEEASVTEAGAEGTTAGV 204
ham AETTTGTGNIGLAALQLPKK--AGNAESKAAKKKESDEEEEEEEENE---NEEAEVEENEQVTNGTSTNST-EVYGGNGSSGGYNGEE--GEEQSVTEAGVEGTTV-G 200
cow -EITPGTGDIGLAAIWLPRK--AGATGKKATKEDESDEEEEEEEEEE----NEAEVDDNEQGINGTSSNST-EVDNGHGSSGGDNGEED-GEEESVTEANTEGITVAG 204
pig GDVTPGTASIGLAALQLPKK--AGDIGKKSAKEEESDEDEEEEEENEE---NEAEVDDNEQGTNGTSTNST-EVDSGNGHSGGDNGEE--GDQESVTEA--QGTTVAG 203
dog EEITPGTGYIGLAAIQLPKK--AGDIRHKATKEEESDEEEEEDEENEE---NEAEVDENGQGINSTSSNST-EAENGNGSSAGDNGEG---EEESVTEAHSEGTTEAG 202
hen -----DVGPGGDAASAHQDCKGGQKGTRGDSGDEDSDEEEEEEEEEEE----EEEVEEQDVSVNGTSTNTTAETPHGNNTVAAEEEEDDDEEEEEEEEEEEEAEATTA 176
GGG         GG       GG ···cell binding····S···    RGD                         S
man RQGKGTSKTTTSPN-GGFEPTTPPQ-VYRTTSPPFGKTTTVEYEGEYEYT-GA-NEYDNGYEIYESENGEPRGDNYRAYEDEYSYFKGQGYDGYDGQNYY-HHQ 301
mse RELTS-VGTQTAVLLNGFQQTTPPPEAYGTTSPPIRKSSTVEYGGEYEQT-G--NEYNNEYEVYDNENGEPRGDTYRAYEDEYSYYKGHGYEGYEGQNYYY-HQ 308  
rat RELTS-YGTTTAVLLNGFQQTTPPPEAYGTTSPPARKSSTVEYGEEYEQI-G--NEYNTAYETYDENNGEPRGDTYRAYEDEYSYYKGHGYEGYEGQDYYY-HQ 303  
ham REQIS-DGPTTAVLMNGFQYTTPPPEAYGTTSPPFRKPTTVEYWGEYEQT-GN-NEYNGEYQIYDNENGEPRGDNYRAYEDEYSYYKGRGYEGYDGQDYYY-HQ 300  
cow -------ETTTSPN-GGFKPTTPHQEVYGTTPPPFGKITTP---GEYEQT-GT-NEYDNGYEIYESENGDPRGDNYRAYEDEYSYYKGRGYDSYDGQDYYS-HQ 294  
pig EQDNGGAKTTTSPN-GGLEPTPPPQDISGTTLPPSGKTTTPEYEGEYEQT-GA-HEYDNGYEIYESENGEPRGDSYRAYEDEYSYYKGRSYNSYGGHDYY---- 300  
dog KQNNGGSKTTLSPD-GGFEPTTPPPELYGTTTRPSGEATPNGYEEEYEQT-GT-NEYDNGYEVYESENGEPRGDNYRAYEDEYSYYKGHSYDSYDGQDYYYHHQ 303  
hen AATTAQDEVTTLGD---------EQRSEVTTAGE---------QWEYEVTVGARGDEGPTESSYGDQEEPARGDSYRAYEDEYGYYKGHGYDMY-GQDYYY-NQ 260  
NeuAc(α2-3)Gal(β1-4)GlcNac(β1-2)Man(α1-6) NeuAc(α2-6)
\ \
NeuAc(α2-3)Gal(β1-4)GlcNAc(β1-4)               Man(β1-4)GlcNAc(β1-4) GalNAc
\ /                                    \ /
Man(α1-3)                                    GlcNAc NeuAc(α2-3)Gal(β1-3)
/                                                    /
NeuAc(α2-3)Gal(β1-4)GlcNAc(β1-2)                                     Fuc(α1-6)     
(a) (b)
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Figure 3  
 
 
 
 
Figure 4 
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Figure 5 
 
 
 
 
 
 
Figure 6 
  
(a) (b)
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Figure 7 
 
 
Figure 8 
 
 
 
Figure 9 
BSP
